1. Home
  2. SONM vs TNXP Comparison

SONM vs TNXP Comparison

Compare SONM & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • TNXP
  • Stock Information
  • Founded
  • SONM 1999
  • TNXP 2007
  • Country
  • SONM United States
  • TNXP United States
  • Employees
  • SONM N/A
  • TNXP N/A
  • Industry
  • SONM Telecommunications Equipment
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • TNXP Health Care
  • Exchange
  • SONM Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • SONM 15.0M
  • TNXP 15.1M
  • IPO Year
  • SONM 2019
  • TNXP N/A
  • Fundamental
  • Price
  • SONM $2.88
  • TNXP $0.14
  • Analyst Decision
  • SONM
  • TNXP Strong Buy
  • Analyst Count
  • SONM 0
  • TNXP 2
  • Target Price
  • SONM N/A
  • TNXP $53.50
  • AVG Volume (30 Days)
  • SONM 18.3K
  • TNXP 25.7M
  • Earning Date
  • SONM 11-12-2024
  • TNXP 11-07-2024
  • Dividend Yield
  • SONM N/A
  • TNXP N/A
  • EPS Growth
  • SONM N/A
  • TNXP N/A
  • EPS
  • SONM N/A
  • TNXP N/A
  • Revenue
  • SONM $69,288,000.00
  • TNXP $12,458,000.00
  • Revenue This Year
  • SONM N/A
  • TNXP $62.53
  • Revenue Next Year
  • SONM $107.78
  • TNXP $26.17
  • P/E Ratio
  • SONM N/A
  • TNXP N/A
  • Revenue Growth
  • SONM N/A
  • TNXP N/A
  • 52 Week Low
  • SONM $2.32
  • TNXP $0.12
  • 52 Week High
  • SONM $10.70
  • TNXP $22.08
  • Technical
  • Relative Strength Index (RSI)
  • SONM 55.47
  • TNXP 32.40
  • Support Level
  • SONM $2.67
  • TNXP $0.14
  • Resistance Level
  • SONM $2.95
  • TNXP $0.18
  • Average True Range (ATR)
  • SONM 0.29
  • TNXP 0.02
  • MACD
  • SONM 0.03
  • TNXP 0.02
  • Stochastic Oscillator
  • SONM 42.39
  • TNXP 28.11

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the United States, and to Bell, Rogers, and Telus Mobility in Canada. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: